Exploring the Implementation of Quality Care Programs for Patients with Myeloproliferative Neoplasms

Bruce Feinberg, DO; Kathy Oubre, Michael Reff, RPh, MBA; Jamile M. Shammo, MD; and Ruben Mesa, MD, discuss the incorporation of quality care programs for improved disease management and patient care for MPNs.
EP 1: Overview of Myeloproliferative Neoplasms (MPNs)

February 24th 2021

Jamile Shammo, MD, reviews the various types of MPNs [myeloproliferative neoplasms] and how they differ from MDS [myelodysplastic syndrome].

EP 2: Diagnosis of MPNs

February 24th 2021

Ruben Mesa, MD, discusses presentation and diagnosis of MPNs as well as life expectancies of ET [essential thrombocythemia], PV [polycythemia vera], and MF [myelofibrosis].

EP 3: Approaching MPN Patient Treatment

March 3rd 2021

Jamile Shammo, MD, reviews methods for approaching patient treatment of MPNs and how it differs for each patient and symptom.

EP 4: Building the Best Oncology Care Process for MPNs

March 3rd 2021

Kathy Oubre and Michael Reff, RPh, MBA, explain how they built the process and success factors of quality oncology care for MPNs.

EP 5: Heterogeneity of Therapy in Patients With MPNs

March 10th 2021

Ruben Mesa, MD, and Jamile M. Shammo, MD, discuss available treatment options, such as JAK inhibitors, and the goals of treatment for patients with MPNs.

EP 6: Practice Guidelines and the Decision-Making Process for MPNs

March 10th 2021

Michael Reff, RPh, MBA, and Kathy Oubre explain the internal guiding documents that aid a practice’s decision-making and workflow when treating patients with MPNs.

EP 7: The Application of Guideline Adherence Around MPNs

March 17th 2021

Ruben Mesa, MD, and Jamile M. Shammo, MD, discuss treatment guidelines, pathways, and pharmacologic treatment options that play a role in the standard of care for MPNs.

EP 8: Integrating New Practice Guidelines and Processes for MPNs

March 17th 2021

Kathy Oubre and Michael Reff, RPh, MBA, reflect on reactions to new guidelines for managing MPNs and how practices are integrating the new process, while Ruben Mesa, MD, shares his experience.

EP 9: Impact of Telehealth on MPNs During COVID-19

March 24th 2021

Jamile M. Shammo, MD, comments on telehealth and the impact on patients who have MPNs during the COVID-19 pandemic.

EP 10: Using Technology to Increase Patient Adherence in MPNs

March 24th 2021

Michael Reff, RPh, MBA; Kathy Oubre; and Ruben Mesa, MD, discuss how telehealth, technology, and innovation have increased patient adherence and created touch points with patients with MPNs.

EP 11: Individual Treatment Plans for MPN Patients

March 31st 2021

Jamile Shammo, MD, discusses creating individual treatment plans for MPNs and following patients to have a better understanding of how they will respond to treatment.

EP 12: Stem Cell Transplantation Intervention for MF

March 31st 2021

Ruben Mesa, MD, shares his thoughts on stem cell transplantation related to progression-free survival in MPNs, and Kathy Oubre highlights the importance of good working relationships.

EP 13: Enhancing Patient Adherence in MPN

April 7th 2021

Kathy Oubre and Michael Reff, RPh, MBA, address the lack of treatment adherence among patients with MPNs and how to overcome this with a best-practice approach.

EP 14: Overcoming Barriers to Treatment Adherence in MPN

April 7th 2021

Michael Reff, RPh, MBA, provides insight on adherence programs for MPNs and discusses why patients may not be adherent to therapies.

EP 15: Patient Compliance: Role of Pharmacists on MPN Care Teams

April 14th 2021

Jamile Shammo, MD, Ruben Mesa, MD, and Michael Reff, RPh, MBA, discuss having pharmacists on MPN care teams and the effect they have on patient compliance.

EP 16: Management of MPN: Benchmarks For Quality Care

April 14th 2021

Ruben Mesa, MD, leads a discussion on key benchmarks and final thoughts about good-quality care programs for patients with MPNs, including parameters for judging efficacy and safety.